Niu J - Search Results

1

Efficacy and safety of a nanoparticle therapeutic vaccine in patients with chronic hepatitis B: A randomized clinical trial.

Wei L, Zhao T, Zhang J, Mao Q, Gong G, Sun Y, Chen Y, Wang M, Tan D, Gong Z, Li B, Niu J, Li S, Gong H, Zou L, Zhou W, Jia Z, Tang Y, Fei L, Hu Y, Shang X, Han J, Zhang B, Wu Y. Wei L, et al. Among authors: niu j. Hepatology. 2022 Jan;75(1):182-195. doi: 10.1002/hep.32109. Epub 2021 Dec 8. Hepatology. 2022. PMID: 34396571 Clinical Trial.

2

[A multicenter, randomized, open-label study of the safety and effectiveness of pegylated interferon alpha 2b and interferon alpha 2b in treating HBeAg positive chronic hepatitis B patients].

Zhao H, Si CW, Wei L, Wan MB, Ying YK, Hou JL, Niu JQ. Zhao H, et al. Zhonghua Gan Zang Bing Za Zhi. 2006 May;14(5):323-6. Zhonghua Gan Zang Bing Za Zhi. 2006. PMID: 16732903 Clinical Trial. Chinese.

3

Genotype B and younger patient age associated with better response to low-dose therapy: a trial with pegylated/nonpegylated interferon-alpha-2b for hepatitis B e antigen-positive patients with chronic hepatitis B in China.

Zhao H, Kurbanov F, Wan MB, Yin YK, Niu JQ, Hou JL, Wei L, Wang GQ, Tanaka Y, Mizokami M, Si CW. Zhao H, et al. Clin Infect Dis. 2007 Feb 15;44(4):541-8. doi: 10.1086/511042. Epub 2007 Jan 11. Clin Infect Dis. 2007. PMID: 17243057 Clinical Trial.

4

[The degree of HBV suppression with 24 week telbivudine- or lamivudine-treatment in hepatitis B patients predicts the efficacy of the treatment at week 52].

Jia JD, Hou JL, Yin YK, Xu DZ, Tan DM, Niu JQ, Zhou XQ, Wang YM, Zhu LM, He YW, Ren H, Wan MB, Chen CW, Wu SM, Chen YG, Xu JZ, Wang QH, Wei L, Ma H. Jia JD, et al. Zhonghua Gan Zang Bing Za Zhi. 2007 May;15(5):342-5. Zhonghua Gan Zang Bing Za Zhi. 2007. PMID: 17524265 Clinical Trial. Chinese.

5

Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial.

Hou J, Yin YK, Xu D, Tan D, Niu J, Zhou X, Wang Y, Zhu L, He Y, Ren H, Wan M, Chen C, Wu S, Chen Y, Xu J, Wang Q, Wei L, Chao G, Constance BF, Harb G, Brown NA, Jia J. Hou J, et al. Among authors: niu j. Hepatology. 2008 Feb;47(2):447-54. doi: 10.1002/hep.22075. Hepatology. 2008. PMID: 18080339 Clinical Trial.

6

A randomized controlled phase IIb trial of antigen-antibody immunogenic complex therapeutic vaccine in chronic hepatitis B patients.

Xu DZ, Zhao K, Guo LM, Li LJ, Xie Q, Ren H, Zhang JM, Xu M, Wang HF, Huang WX, Bai XF, Niu JQ, Liu P, Chen XY, Shen XL, Yuan ZH, Wang XY, Wen YM. Xu DZ, et al. PLoS One. 2008 Jul 2;3(7):e2565. doi: 10.1371/journal.pone.0002565. PLoS One. 2008. PMID: 18596958 Free PMC article. Clinical Trial.

7

Comparative analysis of portal cell infiltrates in antimitochondrial autoantibody-positive versus antimitochondrial autoantibody-negative primary biliary cirrhosis.

Jin Q, Moritoki Y, Lleo A, Tsuneyama K, Invernizzi P, Moritoki H, Kikuchi K, Lian ZX, Hirschfield GM, Ansari AA, Coppel RL, Gershwin ME, Niu J. Jin Q, et al. Among authors: niu j. Hepatology. 2012 May;55(5):1495-506. doi: 10.1002/hep.25511. Epub 2012 Apr 4. Hepatology. 2012. PMID: 22135136 Free PMC article.

8

Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis B.

Wang J, Cai Y, Ji H, Feng J, Ayana DA, Niu J, Jiang Y. Wang J, et al. Among authors: niu j. J Interferon Cytokine Res. 2012 Jun;32(6):248-53. doi: 10.1089/jir.2011.0109. Epub 2012 Feb 3. J Interferon Cytokine Res. 2012. PMID: 22304300 Free PMC article.

9

Treatment with telbivudine positively regulates antiviral immune profiles in Chinese patients with chronic hepatitis B.

Ma L, Cai YJ, Yu L, Feng JY, Wang J, Li C, Niu JQ, Jiang YF. Ma L, et al. Among authors: niu jq. Antimicrob Agents Chemother. 2013 Mar;57(3):1304-11. doi: 10.1128/AAC.02181-12. Epub 2012 Dec 28. Antimicrob Agents Chemother. 2013. PMID: 23274669 Free PMC article.

10

Downregulation and altered function of natural killer cells in hepatitis B virus patients treated with entecavir.

Zhao PW, Jia FY, Shan YX, Ji HF, Feng JY, Niu JQ, Ayana DA, Jiang YF. Zhao PW, et al. Clin Exp Pharmacol Physiol. 2013 Mar;40(3):190-6. doi: 10.1111/1440-1681.12048. Clin Exp Pharmacol Physiol. 2013. PMID: 23278368 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,026 results

Search Page

Filters